Motley Rice medical attorneys work to uncover aggressive product development and marketing practices that may have caused patients harm. We are reviewing the following medical drugs and devices for potential lawsuits. Intake criteria are included for each. We welcome questions and opportunities to pursue working together.
- Endoscope/Duodenoscope Superbug Infections
- IVC Filters
- Laparoscopic Power Morcellators
- Metal-on-Metal Hip Replacement Systems
- Transvaginal/Pelvic Mesh
- Talcum Powder
Endoscope/ Duodenoscope Superbug Infection Lawsuits
We are reviewing potential cases involving patients who became seriously ill following a medical procedure between Jan. 1, 2010 and Oct. 31, 2015 involving an endoscope manufactured by Olympus Corporation. Illnesses may include pneumonia or the “superbug,” or death from illness complications.
Essure is a hysteroscopic sterilization procedure, a type of tubal sterilization that does not require an incision. We are accepting potential claims involving women who underwent the procedure and have experienced side effects such as chronic pelvic pain, ectopic pregnancy, migration of the device or a device component, puncture or tear of the uterus or colon, severe migraines and allergic reactions, additional surgeries including hysterectomies, or who have died following the procedure. The FDA has added a black box warning and is requiring Bayer to conduct a clinical study.
IVC filters are small, cage-like devices designed to be implanted in the inferior vena cava (IVC) to prevent blood clots moving from the lower body to the lungs or heart. Patients who are at risk of developing blood clots, but who are not candidates for blood thinner medication, often have IVC filters implanted. We are accepting cases with complications and/or positive product ID of all Bard or Cook medical retrievable filters. Don Migliori is on the PSC.
Laparoscopic Power Morcellators
We represent and are investigating cases of women who underwent uterine fibroid removal through use of laparoscopic power morcellators and subsequently were diagnosed with leiomyosarcoma cancer (cancerous uterine fibroids), a gynecologic cancer or occult malignancy.
Metal-on-Metal Hip Replacement Systems
Metal-on-metal hip devices were originally thought to be a more durable alternative to ceramic or plastic models, but studies have found that about one in 12 recipients of MoM devices may require corrective surgery within five years of implantation. Side effects can include osteolysis, metallosis, chronic pain, dislocation or loosening of implant, infection, pseudotumors and fractured hipbone, among others, necessitating one or more device replacement surgeries. Motley Rice attorneys hold a number of leadership roles, and currently represent and/or are reviewing new claims in MoM hip replacement cases involving:
- DePuy® Orthopaedics ASR™ XL Acetabular Hip Replacement System (implanted between 2005 and 2010)
- DePuy® Pinnacle® Modular Hip Replacement System (implanted between 2001 and 2010)
- Stryker® Rejuvenate and ABG II Modular-Neck Hip Stems
- Wright Medical Technology Hip Replacements Conserve®, Dynasty®, Profemur® and Lineage® products
- Zimmer Durom®Cup Hip Replacement Device
Transvaginal mesh is a medical device used to treat pelvic organ prolapse and stress urinary incontinence, conditions that may occur after pregnancy and childbirth. TVM has been linked to numerous side effects, including erosion of vaginal tissue, infection, urinary problems and bowel perforations, among others. We continue to review cases of women suffering from serious complications and subsequent surgeries following the placement of devices manufactured by Bard, Johnson & Johnson/Ethicon, Boston Scientific, and American Medical Systems. Motley Rice attorneys have negotiated major settlements with multiple defendants and continue to play a number of leadership and trial roles.
Frequent, long-term use of talcum powder on the genitals and perineal area, including on sanitary napkins, has been associated with an increased risk of ovarian cancer. We represent and are reviewing talc cases.
Taxotere is an anti-cancer chemotherapy drug that also goes by the generic name Docetaxel. We are reviewing cases involving women who took Taxotere and have suffered permanent hair loss or permanent significant alopecia for at least six months.
Viagra & Revatio
Zofran, manufactured by GlaxoSmithKline, is an antiemetic drug used to treat post-operative and chemotherapy induced nausea and vomiting. It was never approved for morning sickness in pregnant women. GlaxoSmithKline was fined by the DOJ for off-label marketing. We are accepting cases involving children who were born with a congenital heart defect or oral cleft who had prenatal exposure to Zofran in the first trimester. The child cannot have a chromosomal abnormality or genetic syndrome. We are accepting both the brand and generic “Ondansetron” cases. Zofran went generic in 2006. Kimberly Barone Baden is a PSC co-lead in this litigation.